The COVID-19 pandemic has brought with it a daily onslaught of unsettling numbers and charts related to infection numbers, hospitalizations, and death rates. But Mark Abraham ’04 B.A., executive director of DataHaven, said sometimes focusing on positive...
Two Yale emergency physicians have designed a tool to help clinicians better identify COVID-19 patients whose condition is likely to worsen rapidly and who will need intensive care within 24 hours.
The tool, which uses predictive modeling, is called the ...
The coronavirus pandemic has, in the words of Dr. F. Perry Wilson, a.k.a. “The Methods Man,” ushered in a “perfect storm of scientific misinformation.”
Scientists are releasing new studies at an unprecedented pace, the public is clamoring for more...
A team of Yale researchers has developed a new app, Hunala, that aims to be the “Waze for coronavirus.”
Led by Sterling Professor Nicholas Christakis, a physician and social networks expert, with colleagues in the Yale School of Engineering and Applied...
A site co-founded by two Yale researchers for sharing preliminary medical research called medRxiv (pronounced “med archive”) has become a leading source of scientific discovery related to the COVID-19 pandemic.
Known as a preprint server — an online...
A highly unusual school semester has ended, and the coming summer will be unlike any in memory. Families are forgoing backyard barbeques and block parties; cities and towns have cancelled carnivals and Fourth of July festivities. Travel carries extra...
Yale clinicians report promising results after treating COVID-19 patients at Yale New Haven Hospital (YNHH) with a drug that reduces hyperinflammation in cancer patients undergoing immunotherapy.
The team initially gave the drug, tocilizumab, to the most...
Researchers at Yale have identified a molecule that plays a key role in the body’s inflammatory response to overeating, which can lead to obesity, diabetes, and other metabolic diseases. The finding suggests that the molecule could be a promising...
Researchers at Yale have found that injury to endothelial cells — the cells lining blood vessels — may be a key driver of COVID-19 severity and death. The findings, published in the June 30 edition of The Lancet Haematology, may help to explain the...